Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

FDA Issues Warning To Aytu Biopharma Over Misleading Ads For ADHD Drug Adzenys XR-ODT

Author: Benzinga Newsdesk | September 16, 2025 11:24am

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aytu-biopharma-716599-09092025

Posted In: AYTU


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist